153 related articles for article (PubMed ID: 34238790)
21. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
22. Risk of skin cancer development in 672 patients affected by actinic keratosis.
Dika E; Fanti PA; Misciali C; Vaccari S; Crisman G; Barisani A; Baraldi C; Ribero S; Patrizi A
G Ital Dermatol Venereol; 2016 Dec; 151(6):628-633. PubMed ID: 26381460
[TBL] [Abstract][Full Text] [Related]
23. Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp.
Brodland DG; Roenigk RK
Mayo Clin Proc; 1988 Sep; 63(9):887-96. PubMed ID: 3412028
[TBL] [Abstract][Full Text] [Related]
24. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
[TBL] [Abstract][Full Text] [Related]
26. Clinical recognition of actinic keratoses in a high-risk population: how good are we?
Venna SS; Lee D; Stadecker MJ; Rogers GS
Arch Dermatol; 2005 Apr; 141(4):507-9. PubMed ID: 15837871
[TBL] [Abstract][Full Text] [Related]
27. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
[TBL] [Abstract][Full Text] [Related]
28. P53 staining index and zonal staining patterns in actinic keratoses.
Javor S; Gasparini G; Biatta CM; Cozzani E; Cabiddu F; Ravetti JL; Vellone VG; Parodi A
Arch Dermatol Res; 2021 May; 313(4):275-279. PubMed ID: 32642809
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
30. Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.
Lanoue J; Chen C; Goldenberg G
Cutis; 2016 Jun; 97(6):415-20. PubMed ID: 27416085
[TBL] [Abstract][Full Text] [Related]
31. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinoma.
Schmitz L; Grinblat B; Novak B; Hoeh AK; Händschke K; von Dobbeler C; Bierhoff E; Szeimies RM; Gambichler T; Torezan L; Festa-Neto C; Stockfleth E; Dirschka T
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1535-1540. PubMed ID: 30972880
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of actinic keratoses in older adults].
Szeimies RM; Stege H
Dermatologie (Heidelb); 2023 Sep; 74(9):663-669. PubMed ID: 37594513
[TBL] [Abstract][Full Text] [Related]
34. [Actinic Keratosis].
Dejaco D; Hauser U; Zelger B; Riechelmann H
Laryngorhinootologie; 2015 Jul; 94(7):467-79; quiz 480-1. PubMed ID: 26125293
[TBL] [Abstract][Full Text] [Related]
35. The many clinico-pathologic faces of actinic keratosis: an atlas.
Massone C; Cerroni L
Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
[TBL] [Abstract][Full Text] [Related]
36. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
37. Are actinic keratoses really squamous cell cancer? How do we know if they would become malignant?
Conforti C; Beninati E; Dianzani C
Clin Dermatol; 2018; 36(3):430-432. PubMed ID: 29908585
[TBL] [Abstract][Full Text] [Related]
38. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
39. New wine in old bottles: the coming deluge of aggressive cutaneous cancers and precancers.
Wassef C; Lee B; Lambert PC; Patel L; Lambert WC
Skinmed; 2014; 12(3):183-5. PubMed ID: 25134315
[No Abstract] [Full Text] [Related]
40. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
